Immediate loading of single implants in the anterior maxilla
- Conditions
- Implant dentistryOral Health
- Registration Number
- ISRCTN12935478
- Lead Sponsor
- White Clinic Dental Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 35
1. Patients with one to four single-tooth gaps, or patients in need of replacement of one to four severely compromised, non–restorable teeth in the anterior areas of the maxilla (incisors, canines, first and second premolars)
2. Good state of systemic health
3. Good oral hygiene
4. Age > 18 years
5. Dentition in the opposite arch
6. Willingness to participate in the follow–up study, attending all annualperiodic examinations/controls
General exclusion criteria:
1. Uncontrolled or not properly treated diabetes with high blood sugar levels;
2. The presence of immunosuppression
3. History of head and neck cancer with radio– and chemotherapy
4. The presence of blood diseases
5. The presence of psychological or psychiatric diseases
6. Patients in treatment with anticoagulants
7. Patients in treatment with oral/intravenous aminobisphosphonates
The local exclusion criteria:
1. The absence of enough bone to place an implant of at least 10.0 mm in length and 3.5 mm in diameter
2. The need of major regenerative bone techniques (such as onlay/inlay bone grafting) before implant insertion (minor procedures including guided bone regeneration with granulate and membranes or buccal grafting and inter-proximal procedures were not exclusion criteria)
3. The presence of oral diseases (vesiculobullous diseases, ulcerative diseases, white or red lesions, diseases of the salivary glands, the connective tissue or lymphoid lesions, cystic lesions, benign or malignant tumors of the oral cavity
4. The lack of occlusal contacts in the antagonist arch. History of periodontal disease, the habit of cigarette smoking and the presence of parafunctions were not exclusion criteria for this study; however, patients were advised that these conditions could represent a risk factor for implant therapy.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1. Implant stability is measured using resonance frequency analysis (RFA) at 4, 8 and 12 months after implant placement<br>2. Implant survival is measured using the status of the implant at 4, 8 and 12 months after implant placement<br>3. Implant success is measured using the amount of biological complications (post-operative pain and swelling, peri-implant mucositis, peri-implantitis, peri-implant bone loss without infection) or prosthetic complications (mechanical complications like abutment screw loosening and abutment fracture, chipping and fracture) at 4, 8 and 12 months after implant placement
- Secondary Outcome Measures
Name Time Method There are no secondary outcome measures